Related references
Note: Only part of the references are listed.Optimizing Precision of Hypertension Care to Maximize Blood Pressure Control: A Pilot Study Utilizing a Smartphone App to Incorporate Plasma Renin Activity Testing
Mai Mehanna et al.
CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2021)
Heart Disease and Stroke Statistics-2021 Update A Report From the American Heart Association
Salim S. Virani et al.
CIRCULATION (2021)
MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights
Zhiqiang Pang et al.
NUCLEIC ACIDS RESEARCH (2021)
An untargeted metabolomics study of blood pressure: findings from the Bogalusa Heart Study
William J. He et al.
JOURNAL OF HYPERTENSION (2020)
2020 International Society of Hypertension global hypertension practice guidelines
Thomas Unger et al.
JOURNAL OF HYPERTENSION (2020)
Metabolomic profiling of metoprolol hypertension treatment reveals altered gut microbiota-derived urinary metabolites
Chad N. Brocker et al.
HUMAN GENOMICS (2020)
Untargeted Metabolomics Provides insight into the Mechanisms Underlying Resistant Hypertension
Renata Wawrzyniak et al.
CURRENT MEDICINAL CHEMISTRY (2019)
Emerging Applications of Metabolomics in Clinical Pharmacology
Huanhuan Pang et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2019)
A Unified Conceptual Framework for Metabolic Phenotyping in Diagnosis and Prognosis
Jeremy R. Everett et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension
Mai Mehanna et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Plasma Renin Activity Is a Predictive Biomarker of Blood Pressure Response in European but not in African Americans With Uncomplicated Hypertension
Mai Mehanna et al.
AMERICAN JOURNAL OF HYPERTENSION (2019)
Sphingolipid Metabolic Pathway Impacts Thiazide Diuretics Blood Pressure Response: Insights From Genomics, Metabolomics, and Lipidomics
Mohamed H. Shahin et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
Sodium caprate enables the blood pressure-lowering effect of Ile-Pro-Pro and Leu-Lys-Pro in spontaneously hypertensive rats by indirectly overcoming PepT1 inhibition
John P. Gleeson et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update
Enis Afgan et al.
NUCLEIC ACIDS RESEARCH (2018)
Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits
Evangelos Evangelou et al.
NATURE GENETICS (2018)
Metabolomic characterization of hypertension and dyslipidemia
Chaofu Ke et al.
METABOLOMICS (2018)
Genetic Variants Influencing Plasma Renin Activity in Hypertensive Patients From the PEAR Study (Pharmacogenomic Evaluation of Antihypertensive Responses)
Caitrin W. McDonough et al.
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2018)
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertension
Mai Mehanna et al.
JOURNAL OF CLINICAL HYPERTENSION (2017)
S1P receptor 1-Mediated Anti-Renin-Angiotensin System Cardioprotection: Pivotal Role of Mast Cell Aldehyde Dehydrogenase Type 2
Alice Marino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2017)
Essential hypertension: A filtered serum based metabolomics study
Keerti Ameta et al.
SCIENTIFIC REPORTS (2017)
Current Trends of Hypertension Treatment in the United States
Shreya J. Shah et al.
AMERICAN JOURNAL OF HYPERTENSION (2017)
Comparison of Blood Pressure Control Rates Among Recommended Drug Selection Strategies for Initial Therapy of Hypertension
Kamel A. Gharaibeh et al.
AMERICAN JOURNAL OF HYPERTENSION (2016)
A Genetic Response Score for Hydrochlorothiazide Use Insights From Genomics and Metabolomics Integration
Mohamed H. Shahin et al.
HYPERTENSION (2016)
Identification of Serum Metabolites Associated With Incident Hypertension in the European Prospective Investigation into Cancer and Nutrition-Potsdam Study
Stefan Dietrich et al.
HYPERTENSION (2016)
S1P Signaling and De Novo Biosynthesis in Blood Pressure Homeostasis
Anna Cantalupo et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Pharmacometabolomic Assessments of Atenolol and Hydrochlorothiazide Treatment Reveal Novel Drug Response Phenotypes
D. M. Rotroff et al.
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY (2015)
Sphingosine-1-Phosphate Evokes Unique Segment-Specific Vasoconstriction of the Renal Microvasculature
Zhengrong Guan et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people
Eleni Rapsomaniki et al.
LANCET (2014)
The Role of Plasma Renin Activity, Age, and Race in Selecting Effective Initial Drug Therapy for Hypertension
Gary L. Schwartz et al.
AMERICAN JOURNAL OF HYPERTENSION (2013)
Plasma Lipidomic Profile Signature of Hypertension in Mexican American Families: Specific Role of Diacylglycerols
Hemant Kulkarni et al.
HYPERTENSION (2013)
Pharmacometabolomics Reveals Racial Differences in Response to Atenolol Treatment
William R. Wikoff et al.
PLOS ONE (2013)
Metabolomics: the apogee of the omics trilogy
Gary J. Patti et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
The Plasma Renin Test Reveals the Contribution of Body Sodium-Volume Content (V) and Renin-Angiotensin (R) Vasoconstriction to Long-Term Blood Pressure
John H. Laragh et al.
AMERICAN JOURNAL OF HYPERTENSION (2011)
Measuring Blood Pressure for Decision Making and Quality Reporting: Where and How Many Measures?
Benjamin J. Powers et al.
ANNALS OF INTERNAL MEDICINE (2011)
Drug Therapy for Resistant Hypertension: Simplifying the Approach
Samuel J. Mann
JOURNAL OF CLINICAL HYPERTENSION (2011)
An update on sphingosine-1-phosphate and other sphingolipid mediators
Henrik Fyrst et al.
NATURE CHEMICAL BIOLOGY (2010)
Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics
Julio D. Duarte et al.
EXPERT REVIEW OF CARDIOVASCULAR THERAPY (2010)
Pharmacogenomics of antihypertensive drugs: Rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study
Julie A. Johnson et al.
AMERICAN HEART JOURNAL (2009)
Plasma Renin Test-Guided Drug Treatment Algorithm for Correcting Patients With Treated but Uncontrolled Hypertension: A Randomized Controlled Trial
Brent M. Egan et al.
AMERICAN JOURNAL OF HYPERTENSION (2009)
Modulated Modularity Clustering as an Exploratory Tool for Functional Genomic Inference
Eric A. Stone et al.
PLOS GENETICS (2009)
Predictors of blood pressure response to the angiotensin receptor blocker candesartan in essential hypertension
Vincent J. Canzanello et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Variability in response to antihypertensive drugs
Barry J. Materson
AMERICAN JOURNAL OF MEDICINE (2007)
RhoA/Rho-kinase pathway:: much more than just a modulation of vascular tone.: Evidence from studies in humans
Lorenzo A. Calo et al.
JOURNAL OF HYPERTENSION (2007)
Thiazide-like diuretics attenuate agonist-induced vasoconstriction by calcium desensitization linked to Rho kinase
ZM Zhu et al.
HYPERTENSION (2005)
Phospholipid plasmalogen, a surrogate marker of oxidative stress, is associated with increased cardiovascular mortality in patients on renal replacement therapy
P Stenvinkel et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2004)
Sphingosine kinase modulates microvascular tone and myogenic responses through activation of RhoA/Rho kinase
SS Bolz et al.
CIRCULATION (2003)
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
J Laragh
AMERICAN JOURNAL OF HYPERTENSION (2001)
Laragh's lessons in pathophysiology and clinical pearls for treating hypertension
J Laragh
AMERICAN JOURNAL OF HYPERTENSION (2001)
Sphingosine-1-phosphate reduces rat renal and mesenteric blood flow in vivo in a pertussis toxin-sensitive manner
A Bischoff et al.
BRITISH JOURNAL OF PHARMACOLOGY (2000)
Share Paper
